Patents by Inventor Murray Goodman

Murray Goodman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Somatostatin analogs with inhibitory activity to growth hormone release
    Patent number: 9919065
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic reagents, and methods of making and use thereof.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: March 20, 2018
    Assignee: The Regents of the University of California
    Inventors: Murray Goodman, Sandra Blaj Moore
  • SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE
    Publication number: 20160213793
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic reagents, and methods of making and use thereof.
    Type: Application
    Filed: November 23, 2015
    Publication date: July 28, 2016
    Inventors: Murray Goodman, Sandra Blaj Moore
  • Somatostatin analogs with inhibitory activity to growth hormone release
    Patent number: 9200054
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic reagents, and methods of making and use thereof.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: December 1, 2015
    Assignee: The Regents of the University of California
    Inventors: Murray Goodman, Sandra Blaj Moore
  • SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE
    Publication number: 20140179598
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic reagents, and methods of making and use thereof.
    Type: Application
    Filed: September 18, 2013
    Publication date: June 26, 2014
    Applicant: The Regents of the University of California
    Inventors: Murray Goodman, Sandra Blaj Moore
  • SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE
    Publication number: 20110243845
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic reagents, and methods of making and use thereof.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 6, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Murray Goodman, Sandra Blaj Moore, Zelda Goodman
  • Somatostatin analogs with inhibitory activity to growth hormone release
    Patent number: 7968080
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic reagents, and methods of making and use thereof.
    Type: Grant
    Filed: August 20, 2004
    Date of Patent: June 28, 2011
    Assignee: The Regents of the University of California
    Inventors: Murray Goodman, Zelda Goodman, legal representative, Sandra Blaj Moore
  • Dendrimers as molecular translocators
    Patent number: 7862807
    Abstract: Transport molecules include a dendrimer and a biologically active molecule. The dendrimer of such transport molecules includes at least one guanidine group, at least one protonated guanidine group, at least one protected guanidine group, at least one amidine group, at least one protonated amidine group, at least one protected amidine group, at least one ureido group, at least one protonated ureido group, at least one protected ureido group, at least one thioureido group, at least one protonated thioureido group, or at least one protected thioureido group. The biologically active molecule is bonded to the dendrimer. A method of increasing the bioavailability of a drug includes bonding the drug to a dendrimer of the invention.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: January 4, 2011
    Assignee: University of California, San Diego
    Inventors: Murray Goodman, Churl Min Seong, Guido Harms
  • Dendrimers as Molecular Translocators
    Publication number: 20080221020
    Abstract: Transport molecules include a dendrimer and a biologically active molecule. The dendrimer of such transport molecules includes at least one guanidine group, at least one protonated guanidine group, at least one protected guanidine group, at least one amidine group, at least one protonated amidine group, at least one protected amidine group, at least one ureido group, at least one protonated ureido group, at least one protected ureido group, at least one thioureido group, at least one protonated thioureido group, or at least one protected thioureido group. The biologically active molecule is bonded to the dendrimer. A method of increasing the bioavailability of a drug includes bonding the drug to a dendrimer of the invention.
    Type: Application
    Filed: July 18, 2003
    Publication date: September 11, 2008
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, LG LIFE SCIENCES
    Inventors: Murray Goodman, Churl Min Seong, Guido Harms, Changhee Min, Byung Hyune Choi, Hyun-Ho Chung
  • Somatostatin analogs with inhibitory activity to growth hormone release
    Publication number: 20070041902
    Abstract: Provided are therapeutic and diagnostic somatostatin analogs including radiotherapeutic and radiodiagnostic Reagents, and methods of making and use thereof.
    Type: Application
    Filed: August 20, 2004
    Publication date: February 22, 2007
    Inventors: Murray Goodman, Zelda Goodman, Sandra Moore
  • Dendrimers as molecular translocators
    Publication number: 20060216265
    Abstract: Transport molecules include a dendrimer and a biologically active molecule. The dendrimer of such transport molecules includes at least one guanidine group, at least one protonated guanidine group, at least one protected guanidine group, at least one amidine group, at least one protonated amidine group, at least one protected amidine group, at least one ureido group, at least one protonated ureido group, at least one protected ureido group, at least one thioureido group, at least one protonated thioureido group, or at least one protected thioureido group. The biologically active molecule is bonded to the dendrimer. A method of increasing the bioavailability of a drug includes bonding the drug to a dendrimer of the invention.
    Type: Application
    Filed: July 18, 2003
    Publication date: September 28, 2006
    Inventors: Murray Goodman, Churl Seong
  • Guanidinylation, guanidinoglycosides, uses, and methods of assaying their activity
    Patent number: 6833445
    Abstract: Provided are reagents and methods useful for the synthesis of guanidinylated compounds. Also provided are methods for assaying molecules, including guanidinylated molecules that modulate viral infection and replication.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: December 21, 2004
    Assignee: The Regents of the University of California
    Inventors: Murray Goodman, Yitzhak Tor, Tracy Baker, Nathan Luedtke
  • Lanthionine bridged peptides
    Patent number: 6673769
    Abstract: Disclosed are lanthionine bridged peptides having the structure methods of their preparation and their use as pharmacologically active agents.
    Type: Grant
    Filed: May 10, 2001
    Date of Patent: January 6, 2004
    Inventors: Murray Goodman, George Osapay
  • Guanidinylation, guanidinoglycosides, uses, and methods of assaying their activity
    Publication number: 20030232974
    Abstract: Provided are reagents and methods useful for the synthesis of guanidinylated compounds. Also provided are methods for assaying molecules, including guanidinylated molecules that modulate viral infection and replication.
    Type: Application
    Filed: January 21, 2003
    Publication date: December 18, 2003
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Murray Goodman, Yitzhak Tor, Tracy Baker, Nathan Luedtke
  • Guanidinylation reagents
    Publication number: 20030055214
    Abstract: Trisubstituted N-protected guanidines and methods for use as guanidinylating reagents to yield N-protected guanidine derivatives.
    Type: Application
    Filed: April 30, 2002
    Publication date: March 20, 2003
    Applicant: The Regents of The University of California
    Inventors: Murray Goodman, Konrad Feichtinger, Todd T. Romoff
  • Guanidinylation, guanidinoglycosides, uses, and methods of assaying their activity
    Patent number: 6525182
    Abstract: Provided are reagents and methods useful for the synthesis of guanidinylated compounds. Also provided are methods for assaying molecules, including guanidinylated molecules that modulate viral infection and replication.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: February 25, 2003
    Assignee: Regents of the University of California
    Inventors: Murray Goodman, Yitzhak Tor, Tracy Baker, Nathan Luedtke
  • Lanthionine bridged peptides
    Publication number: 20020165132
    Abstract: Disclosed are lanthionine bridged peptides having the structure 1
    Type: Application
    Filed: May 10, 2001
    Publication date: November 7, 2002
    Inventors: Murray Goodman, George Osapay
  • N-substituted alkylamino acids for use as amino-protecting groups
    Patent number: 6417397
    Abstract: This invention relates to chemical compositions useful in protecting amino functional groups, e.g., during synthetic organic chemistry procedures or in the formulation and/or delivery of prodrugs. The present invention relates particularly to amino-protecting species comprising an acyl group that can form an amide bond with an amino group. The protecting groups of the present invention can be conveniently removed under a wide variety of conditions.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: July 9, 2002
    Assignee: The Regents of the University of California, San Diego
    Inventors: Murray Goodman, Christopher J. Creighton
  • Guanidinylation reagents
    Patent number: 6380358
    Abstract: Trisubstituted N-protected guanidines and methods for use as guanidinylating reagents to yield N-protected guanidine derivatives.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: April 30, 2002
    Assignee: The Regents of the University of California
    Inventors: Murray Goodman, Konrad Feichtinger, Todd T. Romoff
  • Template-assisted triple helical collagen-like structures
    Patent number: 6329506
    Abstract: Synthetic collagen in triple helical conformation and comprising amino acid chains of repeating trimers of highly populated collagen sequences as well as those sequences wherein the proline or hydroxyproline residue is replaced with a peptoid residue. The invention includes methods of preparing synthetic collagen structures having the triple helix conformation present in collagen from collagen-type polypeptides and poly(peptide-peptoid residue) chains by means of a helix-inducing template.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: December 11, 2001
    Assignee: The Regents of the University of California
    Inventors: Murray Goodman, Joseph P. Taulane, Yangbo Feng, Giuseppe Melacini
  • Lanthionine bridged peptides
    Patent number: 6268339
    Abstract: Disclosed are lanthionine bridged peptides having the structure methods of their preparation and their use as pharmacologically active agents.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: July 31, 2001
    Inventors: Murray Goodman, George Osapay